Table 2 Cox regression analysis of outcomes of patients treated with LD colistin and carbapenems for the infection caused by ESBL-producing E. coli and K. pneumoniae. Full size table The overall ...

Researchers conducted a retrospective cohort study at three medical centers. They examined patients with monomicrobial Enterobacteriaceae bacteremia treated with in vitro active therapy for six to 16 ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Antibiotic-resistant bacterial infections often occur in patients with chronic inflammatory intestinal conditions, such as inflammatory bowel disease, and in patients who have taken antibiotics for a ...

In 2024, WHO updated the bacterial priority pathogens list, highlighting organisms that pose the greatest risk to global health. Priority 1 pathogens (critical) include Acinetobacter baumannii ...

While the cost of antibiotic treatment for Enterobacteriaceae infections was a small component of total costs, each extra day of inadequate antibiotic treatment added $750-plus to hospital costs, ...

Carbapenem-resistant Enterobacteriaceae (CRE) refers to Enterobacteriaceae bacteria that are resistant to strong antibiotics known as Carbapenems. Enterobacteriaceae are bacteria that live in a ...

Photo taken in Bangkok, Thailand Investigators conducted a cohort study that compared adverse effects and outcomes among patients with community-acquired urinary tract infection treated with ...

Antibiotic-resistant bacterial infections often occur in patients with chronic inflammatory intestinal conditions, such as inflammatory bowel disease, and in patients who have taken antibiotics for a ...

Cambridge, MA, May 18, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) announced today that it has selected a new preclinical candidate, SMT026738 (“SMT-738”), for development in the fight against ...